Goldman Sachs Removes Diversity Goals
Investors might be surprised to learn that in the past five years, shares of Goldman Sachs (NYSE: GS) have soared 186%. Where ...
The sale, which launched close to midnight on Thursday, came a day after the pharmaceutical group’s founders had sold off a ...
Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...
2h
Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective lowered by The Goldman Sachs Group from $20.00 to ...
GlobalData on MSN1d
Goldman Sachs appoints new CFO for asset management divisionOverbay, who currently holds the position of CFO at Goldman Sachs Bank USA, has a dual role as the CFO at the bank's consumer ...
2d
Goldman Sachs is building a new campus to house its rapidly expanding Dallas office. Two top executives walked BI through the ...
Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price objective hoisted by The Goldman Sachs Group from $13.00 to ...
The issue was discussed by CEO David Solomon and the bank’s partners at their annual meeting in Miami earlier this month, ...
Palantir Technologies (PLTR) has been among the best-performing stocks over the past 12 months, driven by improving earnings, ...
The Wall Street bank has named Tim Freeman and Jared Baker to co-head its new Capital Solutions Group in Australia and New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback